Since many people cannot afford Wegovy given the demand, doctors have prescribed diabetes GLP-1 drugs for off-label use to promote weight loss in obese patients
95% CI: 1.21 to 0.82), and LC n3-PUFA (MD: 0.18 kg/m 2
Having met the MHRAs rigorous standards of safety, quality and effectiveness, the semaglutide tablet has been approved in the UK for weight loss and weight management, says Julian Beach, executive director of healthcare quality and access at the Medicines and Healthcare Regulatory Authority
Interventions of gut microbiota, obesity and depression Lifestyle modifications, including diet, stress management, exercise, and avoiding harmful substances, are commonly recommended for managing altered gut microbiota, obesity, and depression (Table S1)
Clinical trials show an average weight reduction of about 1.3 kg over 8-12 weeks compared to control groups